MAR 28, 2017 4:39 PM PDT

The Pill May Offer Women Cancer Protection for Decades

WRITTEN BY: Xuan Pham

Ever since men and women understood how to have children, they've also been trying to understand how to prevent this process. Now a study finds a popular form of birth control may carry signifcant anticancer benefits.

 A recent survey conducted by the Centers for Disease Control and Prevention found that a whopping 62 percent of American women of childbearing age are using some form of birth control, exercising their right to choose when to have children, and how many children they want. Of the available methods, oral contraceptives are the most popular, used by around 10.6 million women.

The most popular form of oral contraceptive for women is based on a combination of two hormones: estrogen and progesterone. This “combined pill” tricks the body into not releasing an egg each month, which significantly reduces the opportunity for fertilization by a sperm.

Because the pill modulates the woman’s levels of hormones that are associated with cancer, scientists have also been curious to know if the pill itself can influence cancer risks in women.

In analyzing over 46,000 women who were on the pill, scientists at the University of Aberdeen in the United Kingdom made quite a positive conclusion. Oral contraceptives seem to offer women protection from colorectal, ovarian, and endometrial cancers, as compared with women not on the pill. Furthermore, the protection seem to have a lasting effect, with estimates of at least 30 years.

"Because the study has been going for such a long time we are able to look at the very long-term effects, if there are any, associated with the pill," said Dr. Lisa Iversen, the study’s lead author. In particular, patients in this study were followed for up to 44 years, which makes quite an impressive longitudinal study.

"So the protective benefits from using the pill during their reproductive years are lasting for at least 30 years after women have stopped using the pill," says Dr. Iversen.

The results support the findings of other previous short-term studies, which report links between the pill and decreased risk of ovarian, endometrial cancers, along with ectopic pregnancy and ovarian cysts.

And like other studies that find hints of increased risk of breast and cervical cancer with the pill, the current study also report similar findings. However, they say this increased risk is small and seems to go away within 5 years of stopping the pill.

"These results from the longest-running study in the world into oral contraceptive use are reassuring. Specifically, pill users don't have an overall increased risk of cancer over their lifetime and that the protective effects of some specific cancers last for at least 30 years,” Dr. Iversen concluded.

Additional source: MNT

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
APR 01, 2020
Cancer
APR 01, 2020
New immunotherapy for ovarian cancer
Research published recently in the Journal of Experimental Medicine suggests that targeting macrophages in a new kind of ...
MAY 09, 2020
Cancer
MAY 09, 2020
Examining a Combination Therapy Against Gastric Cancer
Often when it comes to treatments for cancer, designing or discovering new leads can take years. One of the common pract ...
MAY 13, 2020
Cancer
MAY 13, 2020
What role does geography play in childhood cancer?
Research published in the International Journal of Health Geographics aims to explain the role that geography plays in p ...
MAY 12, 2020
Drug Discovery & Development
MAY 12, 2020
Novel Drug Approved for Non-Small Cell Lung Cancer
The US Food and Drug Administration (FDA) recently approved a therapeutic for treating metastatic non-small cell lung ca ...
MAY 26, 2020
Genetics & Genomics
MAY 26, 2020
Some People May be Predisposed to Metastasis if They Get Cancer
Cancer can occur for many reasons and is influenced by many different factors, including genes and the environment. But ...
MAY 13, 2020
Drug Discovery & Development
MAY 13, 2020
Approved Treatment for RET-mutant Cancers
A drug was recently approved for treating three types of RET-mutant cancers: 1) non-small cell lung cancer (NSCLC) 2) ad ...
Loading Comments...